Jeena Sikho Lifecare Limited has informed the Exchange regarding Appointment of Ms Shreya Grover as Executive Director (Whole-Time Director) of the company w.e.f. August 27, 2025.
JSLL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Jeena Sikho Lifecare, at its August 27, 2025 meeting, cleared a bundle of corporate actions. It approved a new Employee Stock Option Scheme 2025 covering up to 2,50,000 stock options at an exercise price of ₹2 per share, subject to shareholder nod. Mr. Sahil Jain, a long-tenured internal employee, was appointed as Chief Operating Officer. M/s Ankur Singh & Associates was named as the new Secretarial Auditor for a 5-year term from FY 2025-26 to FY 2029-30. The final dividend of ₹1.10 per equity share (face value ₹2) for FY25 was fixed, with the record date set as September 22, 2025 and payment on or after September 29, 2025, subject to AGM approval. The board also re-designated Ms. Shreya Grover, daughter of Managing Director Manish Grover, from Non-Executive Director to Whole-Time Director (Executive Director) for 5 years, making her a Key Managerial Personnel.
The ESOP at a nominal ₹2 exercise price is highly attractive for employees and will result in share dilution once granted. The elevation of the promoter's daughter (aged 24) to executive board is a clear promoter family succession move, which shareholders should note for governance purposes. The dividend is modest and the new COO is an internal hire, signalling continuity.